Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa

This study has been completed.
Children's Infectious Diseases Clinical Research Unit (KID-CRU), South Africa
Triclinium Johannesburg, South Africa
University of Stellenbosch
HJ-CTC George, South Africa
Information provided by (Responsible Party):
Vakzine Projekt Management GmbH Identifier:
First received: November 18, 2011
Last updated: October 28, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)